SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600132-17-000028
Filing Date
2017-03-20
Accepted
2017-03-20 16:23:01
Documents
1
Period of Report
2017-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149004136704572.html 4  
1 FORM 4 wf-form4_149004136704572.xml 4 3048
  Complete submission text file 0001600132-17-000028.txt   4477
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 EAST 42ND STREET, SUITE 1160 NEW YORK NY 10165
Business Address
Tenenbaum Fabian (Reporting) CIK: 0001641300 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 17701650